|
Hello Visitor |
|
Home > Health Issues and Concerns > Wellness Management > Follow-up |
Follow-up |
Issue
Importance of continued medical follow-up: for future developments In medicine and for your own health.
Background
Survivors of childhood cancer are now growing into adulthood. It is important to continue to have close medical follow-up to detect early any problems that may be a consequence of having had cancer or the cancer treatment. This will not only benefit your health, but also provide information to medical science on potential unknown long-term effects.
Information
It is forecasted that one in every one-thousand adults, by the year 2000, will have been a survivor of childhood cancer. Although the treatment of cancer is what saved their lives, it is unknown what long term complications will result from the treatment as the survivors grow older. Therefore, it is important to continue to have an annual medical examination to detect any problems early. In addition, if medical problems do occur as a result of the prior cancer or treatment, this should be reported by the health care provider to the original treatment medical center. It will be important to collect comprehensive information concerning the long-term medical risks of cancer and of specific treatment regimens in order to better monitor the health status of survivors. This information could potentially prevent these future complications in children presently receiving therapy.
There are other simple follow-up tests which may be needed depending on the type of cancer and treatment you received. The following tables outline the recommended medical follow-up specific to each treatment. Ask your doctor or nurse to point out the treatment you received and review the recommendations with them.
|
|
|
|
Surgery | |||
Nephrectomy | kidney | Chemistry profile, urinalysis, and blood pressure checks | Exercise moderately but avoid contact sports |
Splenectomy | spleen | complete blood count | See your doctor promptly for fever >101.0F, some doctors may recommend prophylactic antibiotic |
Radiation | |||
Abdomen | kidney, liver, bladder | chemistry profile, urinalysis every 3-5 years and blood pressure checks annually | Report any change in stool or blood in stool |
Chest | lungs, breast | Pulmonary function tests if short of breath, monthly self breat exam, exam yearly by a doctor, mammogram periodically after age 25 | Do not smoke, avoid exposure to passive smoke, breast self exam monthly |
Cranial | delay in growth, secondary sex characteristics, possible learning defects | Endocrine evaluation, neuro-psychological testing available upon request, monitor sexual maturation annually | Growth hormone may be considered for growth failure |
Head/neck | eyes, teeth, thyroid gland, pituitary gland | Annual eye exam, dental exam every six months, thyroid function tests, monitor sexual maturation yearly | Maintain good oral/dental hygiene, report difficulty swallowing |
Groin | ovaries | Pelvic exam annually by a doctor | Consider not delaying childbearing if having regular periods, hormone replacement may be necessary if there is ovarian damage |
Lower abdomen | testes | Testicular self exam every month, testicular exam annually by a doctor, sperm count if fertility is in doubt | Testosterone hormone replacement may be indicated |
Extremities | arms, legs | Annual exam of extremities | May require modified sports and exercise program- Ask your doctor |
Spine/Back | spine | Check for scoliosis yearly | |
Chemotherapy | |||
Actinomycin D/ ARA-C | liver | Chemistry profile | |
Adriamycin/ Daunomycin/ Idarubicin | heart | Echocardiogram, cardiac evaluation every five years if normal, cardiology consult if abnormal | Consult doctor before starting a strenuous exercise or weight lifting program, Provide cumulative anthracyline dose information prior to any surgery or during pregnancy |
BCNU/ CCNU/ Bleomycin/ Busulfan | sex organs, lungs | Pelvic exam, sperm count if fertility in doubt, pulmonary function test every 3-5 yrs, CXR every 3-5 yrs | Consider not delaying childbearing if having regular periods, Provide dose information prior to any surgery, consult a doctor before starting a strenuous exercise program |
Cisplatin/ Carboplatin | kidneys, bladder, sex organs, hearing | Chemistry profile with electrolytes, urinalysis every 3-5 years, regular blood pressure checks, pelvic exam yearly, sperm count if fertility is in doubt, audiogram if having hearing difficulties | Consider not delay childbearing if having regular periods |
Cytoxan/ Ifosfamide | kidneys, bladder, sex organs | Same as above except audiogram | Same as above |
DTIC | liver | Chemistry profile | |
L-asparaginase,
Peg-asparaginase |
liver (rare)
pancreas (rare) |
Chemistry profile | |
Methotrexate | liver | Chemistry profile | |
Nitrogen Mustard | sex organs | Pelvic exam yearly, sperm count if fertility is in doubt | Consider not delaying childbearing if having regular periods |
Procarbazine | sex organs, liver, kidney | Pelvic exam yearly, sperm count if fertility is in doubt, urinalysis, chemistry profile | Avoid drinking alcohol, consider not delaying childbearing if having regular periods |
6-Mecaptopurine
6-Thioguanine |
liver | Chemistry profile | |
Vincristine, Velban/VP-16 | liver | Chemistry profile | |
Intrathecal chemotherapy | possible learning deficits | Neuro-psychological testing available | |
Blood Transfusions | liver, immune system | Chemistry profile, hepatitis C test, complete blood count, AIDs virus test if there is a concern | Practice safe sex |
Note
At present there is no one clearinghouse to collect information on long-term complications of childhood cancer. Until such time, all concerns should best be directed to the institution that originally treated the cancer.
Resources
"Caring for Life" booklet
Prepared by: Jerelyn Moffet, RN, MS,CSNP; Peggy Possin, RN, BSN; Sharon Frierdich, RN, MS, CPNP; Paul Gaynon, MD
Schwartz CL. Complications of treatment: Late effects of treatment in long-term survivors of cancer. Cancer Treatment Review l995, 21:355-366.
Nessim, S and Ellis, J. Cancervive: The challenge of life after cancer. Houghton Mifflin Co., Boston, 1991.